| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve Allocation of Income and Absence of Dividends | For |
| O.4 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For |
| O.5 | Reelect Laure Baume as Director | For |
| O.6 | Reelect Moritz Krautkramer as Director | Oppose |
| O.7 | Elect Corine de Bilbao as Director | Abstain |
| O.8 | Elect Pascale Richetta as Director | For |
| O.9 | Approve Compensation of Board Members | For |
| O.10 | Approve Compensation of Philippe Charrier, Chairman of the Board | For |
| O.11 | Approve Compensation of Yves Le Masne, CEO | Oppose |
| O.12 | Approve Compensation of Jean-Claude Brdenk, Vice-CEO | Oppose |
| O.13 | Approve Remuneration of Directors in the Aggregate Amount of EUR 650,000 | For |
| O.14 | Approve Remuneration Policy of Board Members | For |
| O.15 | Approve Remuneration Policy of Philippe Charrier, Chairman of the Board | For |
| O.16 | Approve Remuneration Policy of Yves Le Masne, CEO | Oppose |
| O.17 | Approve Remuneration Policy of Jean-Claude Brdenk, Vice-CEO | Oppose |
| O.18 | Appoint the Auditors | Oppose |
| O.19 | Authorise Share Repurchase | Oppose |
| E.20 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares | For |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 40 Million | Oppose |
| E.22 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 8,076,979 | Oppose |
| E.23 | Approve Issuance of Equity or Equity-Linked Securities for up to 20 Percent of Issued Capital Per Year for Private Placements | Oppose |
| E.24 | Authorise the Board to Increase the Number of Shares Issued in case of Exceptional Demand | Oppose |
| E.25 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights | Oppose |
| E.26 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | Oppose |
| E.27 | Authorize Capitalization of Reserves of Up to EUR 30 Million for Bonus Issue or Increase in Par Value | For |
| E.28 | Authorize up to 1 Percent of Issued Capital for Use in Restricted Stock Plans | Oppose |
| E.29 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Oppose |
| E.30 | Amend Article 2 of Bylaws Re: Corporate Purpose | For |
| E.31 | Amend Article 4 of Bylaws Re: Headquarter | For |
| E.32 | Amend Article 11 of Bylaws Re: Shareholding Disclosure Thresholds | For |
| E.33 | Adopt New Bylaws | For |
| E.34 | Delegate Powers to the Board to Amend Bylaws to Comply with Legal Changes | For |
| E.35 | Authorize Filing of Required Documents/Other Formalities | For |
